Blockage of melatonin receptors impairs p53-mediated prevention of DNA damage accumulation

The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials

(2012) Ye-min Wang et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Reactive oxygen species-induced activation of ERK and p38 MAPK mediates PMA-induced NETs release from human neutrophils

(2012) Ravi S. Keshari et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

The Eumelanin Intermediate 5,6-Dihydroxyindole-2-Carboxylic Acid Is a Messenger in the Cross-Talk among Epidermal Cells

(2012) Daniela Kovacs et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night

(2011) David E. Blask et al.   JOURNAL OF PINEAL RESEARCH

Melatonin Induces Apoptotic Cell Death via p53 in LNCaP Cells

(2011) Chi Hyun Kim et al.   KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY

Gender-related invasion differences associated with mRNA expression levels of melatonin membrane receptors in colorectal cancer

(2011) Josefa León et al.   MOLECULAR CARCINOGENESIS

Melatonin triggers p53Ser phosphorylation and prevents DNA damage accumulation

(2011) R Santoro et al.   ONCOGENE

Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin

(2010) Steven M. Hill et al.   BREAST CANCER RESEARCH AND TREATMENT

Urinary 6-Sulphatoxymelatonin Levels and Risk of Breast Cancer in Premenopausal Women: The ORDET Cohort

(2010) E. S. Schernhammer et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

p53 directly transactivates Δ133p53α, regulating cell fate outcome in response to DNA damage

(2010) M Aoubala et al.   CELL DEATH AND DIFFERENTIATION

A ‘metastasis-prone’ signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics

(2010) Yi Hong et al.   CLINICAL & EXPERIMENTAL METASTASIS

Molecular organization and dynamics of the melatonin MT1 receptor/RGS20/Gi protein complex reveal asymmetry of receptor dimers for RGS and Gi coupling

(2010) Pascal Maurice et al.   EMBO JOURNAL

Correction: Modeling Oncogenic Signaling in Colon Tumors by Multidirectional Analyses of Microarray Data Directed for Maximization of Analytical Reliability

(2010) Magdalena Skrzypczak et al.   PLoS One

Total visual blindness is protective against breast cancer

(2009) Erin E. Flynn-Evans et al.   CANCER CAUSES & CONTROL

Urinary Melatonin Levels and Postmenopausal Breast Cancer Risk in the Nurses' Health Study Cohort

(2009) E. S. Schernhammer et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Nighttime use of special spectacles or light bulbs that block blue light may reduce the risk of cancer

(2009) Martin Alpert et al.   MEDICAL HYPOTHESES

New tales of an old tail

(2009) Jiri Lukas et al.   NATURE

MELATONIN DEFICIENCY AND DISRUPTED CIRCADIAN RHYTHMS IN PEDIATRIC SURVIVORS OF CRANIOPHARYNGIOMA

(2009) J. Lipton et al.   NEUROLOGY

Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines

(2008) Ling Lai et al.   BREAST CANCER RESEARCH AND TREATMENT

Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?

(2008) R Jockers et al.   BRITISH JOURNAL OF PHARMACOLOGY

Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (MTNR1A) in oral squamous-cell carcinoma

(2008) Erina Nakamura et al.   CANCER SCIENCE

Light at Night Co‐distributes with Incident Breast but not Lung Cancer in the Female Population of Israel

(2008) Itai Kloog et al.   CHRONOBIOLOGY INTERNATIONAL

Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of p53 phosphorylation and reactive oxygen species generation

(2008) Tianfeng Chen et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Urinary 6-Sulfatoxymelatonin Levels and Risk of Breast Cancer in Postmenopausal Women

(2008) E. S. Schernhammer et al.   JNCI-Journal of the National Cancer Institute

Physiological effects of melatonin: Role of melatonin receptors and signal transduction pathways

(2008) S PANDIPERUMAL et al.   PROGRESS IN NEUROBIOLOGY